Podcast/ R&D/ Views & Analysis/ Views and analysis Biotech strategy and nanomedicine: the pharmaphorum podcast mike.smith@pharmaphorum.com Biotech, Blueberry Therapeutics, dermatology, Nanomedicine 0 Comment For episode 5 of the pharmaphorum podcast Dominic Tyer met Blueberry Therapeutics’ CEO Dr John Ridden at The Share X Biotech strategy and nanomedicine: the pharmaphorum podcast https://pharmaphorum.com/r-d/biotech-strategy-and-nanomedicine/
Biotech, Blueberry Therapeutics, dermatology, Nanomedicine
0 Comment
